SEC Form 4 · accession 0001185185-18-001621
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director · 10% Owner
Period of report
Aug 30, 2018
Accepted (ET)
Aug 31, 2018 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 30, 2018 | S | 50,000 | $1.8652 | D | 2,224,760 | D |
Table II — derivative securities
No Table II lines on this filing.